Page last updated: 2024-09-04

ter 286 and Cancer of Lung

ter 286 has been researched along with Cancer of Lung in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	4 (80.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Belt, RJ; Boccia, RV; Brown, GL; Burris, HA; Caldwell, DC; Edelman, MJ; Englund, CW; Fidias, PM; Huberman, MS; Jones, M; Keck, JG; Kolevska, T; Lynch, TJ; Melnyk, O; Meng, L; Mills, GM; Rabin, MS; Sequist, LV; Temel, JS	1
Lilenbaum, R; Raez, LE	1
Edelman, MJ	1
Cerna, C; Izbicka, E; Lawrence, R; Sanderson, PE; Von Hoff, DD	1

Reviews

3 review(s) available for ter 286 and Cancer of Lung

Article	Year
Current data and ongoing trials in patients with recurrent non-small-cell lung cancer. Clinical lung cancer, 2004, Volume: 5, Issue:6 Topics: Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cytotoxins; Docetaxel; ErbB Receptors; Erlotinib Hydrochloride; Glutamates; Glutathione; Guanine; Humans; Lung Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Pemetrexed; Prodrugs; Prognosis; Quinazolines; Taxoids	2004
New developments in chemotherapy for advanced non-small cell lung cancer. Current opinion in oncology, 2006, Volume: 18, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Epothilones; Glutamates; Glutathione; Guanine; Humans; Lung Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pemetrexed; Pyrazines	2006
Novel cytotoxic agents for non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2006, Volume: 1, Issue:7 Topics: Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cytotoxins; Drug Delivery Systems; Epothilones; Glutathione; Humans; Lung Neoplasms; Taxoids; Tubulin Modulators	2006

Trials

1 trial(s) available for ter 286 and Cancer of Lung

Article	Year
Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cytotoxins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glutathione; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome	2009

Article

Year

Phase 1-2a multicenter dose-ranging study of canfosfamide in combination with carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, Volume: 4, Issue:11

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carboplatin; Carcinoma, Non-Small-Cell Lung; Cytotoxins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glutathione; Humans; Injections, Intravenous; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Paclitaxel; Treatment Outcome

2009

Other Studies

1 other study(ies) available for ter 286 and Cancer of Lung

Article	Year
Activity of TER286 against human tumor colony-forming units. Anti-cancer drugs, 1997, Volume: 8, Issue:4 Topics: Antineoplastic Agents, Alkylating; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colonic Neoplasms; Cytotoxins; Drug Screening Assays, Antitumor; Glutathione; Humans; Kinetics; Lung Neoplasms; Neoplastic Stem Cells	1997